Personal information

Websites & social links

Institute for Interdisciplinary Innovation in healthcare

Other IDs

ResearcherID: C-8963-2016
Loop profile: 344104

Keywords

Pharmaceutical, Healthcare, Public-Private Partnership, Intellectual Property / IP, Innovation, Business models

Countries

Belgium

Activities

Collapse all

Employment (5)

Université Libre de Bruxelles: Brussels, BE

2020-12-01 to present | Professor Health & Society (Faculty of Medicine & Solvay Brussels School)
Employment
Source: Self-asserted source
Hilde Stevens

Université Libre de Bruxelles: Bruxelles, BE

2016-10-01 to 2020-11-30 | Associate Professor (Faculty of Medicine)
Employment
Source: Self-asserted source
Hilde Stevens

Université Libre de Bruxelles: Bruxelles, BE

2015-10-01 to 2016-09-30 | Post-Doctoral Researcher (Faculty of Medicine)
Employment
Source: Self-asserted source
Hilde Stevens

Business integrated Intellectual Property (BiIP): Brussels - BELGIUM, BE

2007-09-01 to 2010-08-31 | Patent Engineer
Employment
Source: Self-asserted source
Hilde Stevens

Altran : Brussels - BELGIUM, BE

2006-09-01 to 2007-08-01 | Project engineer (Consulting)
Employment
Source: Self-asserted source
Hilde Stevens

Education and qualifications (9)

Medical Evaluation and Technology Assessment (ME-TA): Ghent, BE

2019-05-06 to 2019-05-09 | Economic evaluations of medical interventions: practical training
Qualification
Source: Self-asserted source
Hilde Stevens

Terrapinn Holdings Ltd: London, London, GB

2017-05-03 to 2017-05-05 | Women in Management
Qualification
Source: Self-asserted source
Hilde Stevens

Universiteit Utrecht: Utrecht, Utrecht, NL

2017-04-04 to 2017-04-30 | Fundamentals of Global Health (Epidemiology)
Education
Source: Self-asserted source
Hilde Stevens

KU Leuven: Leuven, BE

2010-09-01 to 2015-06-15 | PhD (Department of Pharmaceutical & Pharmacological Sciences, Research Centre for Clinical Pharmacology and Pharmacotherapy)
Education
Source: Self-asserted source
Hilde Stevens

KU Leuven: Leuven, BE

2007-10-01 to 2010-09-01 | Master in Intellectuele Rechten/Magistère en Droits Intellectuels (Centre for IT and IP Law)
Education
Source: Self-asserted source
Hilde Stevens

Universite de Strasbourg Centre d'Etudes Internationales de la Propriete Intellectuelle: Strasbourg, Alsace, FR

2008-01-01 to 2010-06-01 | European Patent Rights and PCT
Qualification
Source: Self-asserted source
Hilde Stevens

Vlerick Business School: Ghent, BE

2005-09-01 to 2006-06-30 | Master in General Management (General Management)
Education
Source: Self-asserted source
Hilde Stevens

Universiteit Gent: Gent, BE

2004-10-01 to 2005-06-30 | Master in Education (teacher degree) (Psychology and Pedagogical Sciences)
Education
Source: Self-asserted source
Hilde Stevens

Universiteit Gent: Gent, BE

2000-10-01 to 2005-06-30 | Master in Biomedical Sciences (Medicine and healthcare sciences)
Education
Source: Self-asserted source
Hilde Stevens

Professional activities (5)

KU Leuven: Leuven, Vlaanderen, BE

2018-01-01 to present | Guest Professor (Department of Pharmaceutical & Pharmacological Sciences, Research Centre for Clinical Pharmacology and Pharmacotherapy)
Invited position
Source: Self-asserted source
Hilde Stevens

Frontiers Media SA: Lausanne, VD, CH

2016-06-01 to present | Associate Editor (Regulatory Science)
Invited position
Source: Self-asserted source
Hilde Stevens

EUPATI Belgium: Brussels - BELGIUM, BE

2016-10-01 to 2020-02-01 | Vice-chair
Service
Source: Self-asserted source
Hilde Stevens

KU Leuven: Leuven, Vlaanderen, BE

2013-03-15 | KU Leuven PhD Interaction Day (Department of Pharmaceutical & Pharmacological Sciences, Research Centre for Clinical Pharmacology and Pharmacotherapy)
Distinction
Source: Self-asserted source
Hilde Stevens

KBC Bank NV: Brussels, Brussels, BE

2006-06-27 | KBC Award honoring the student team of the Masters in General Management with best in-company project
Distinction
Source: Self-asserted source
Hilde Stevens

Funding (6)

ADVANCE

2019-10 to 2022-04 | Grant
European Commission (Brussels - BELGIUM, BE)
GRANT_NUMBER: 2019-1-NL01-KA203-060286
Source: Self-asserted source
Hilde Stevens

Access to Innovative Health Technologies - The case of vaccines

2018-11 to 2018-11 | Contract
Fondation Brocher (Geneva, CH)
Source: Self-asserted source
Hilde Stevens

The role of public-private partnerships in the provision of equitable access to medical care to the patients in low- and middle-income countries

2017-04 to 2017-04 | Grant
Fondation Brocher (Geneva, CH)
Source: Self-asserted source
Hilde Stevens

Baillet Latour Chair in Translational Medicine

2016-10 to 2022-09 | Grant
Fonds Baillet Latour (Brussels - BELGIUM, BE)
Source: Self-asserted source
Hilde Stevens

Patient Organizations in Biomedical Public-Private Partnerships

2015-04 to 2015-04 | Grant
Fondation Brocher (Geneva, CH)
Source: Self-asserted source
Hilde Stevens

Mapping of EU and US Precompetitive Public-Private Partnerships (PPPs)

2013-07 to 2013-07 | Grant
Fondation Brocher (Geneva, FR)
Source: Self-asserted source
Hilde Stevens

Works (11)

Medicine and Society

Frontiers in Medicine
2020-10-14 | Edited book
DOI: 10.3389/fmed.2020.570551
Part of ISSN: 2296-858X
Source: Self-asserted source
Hilde Stevens

COVID-19, The Quarantine-Virus Disease

Frontiers for Young Minds
2020-07-29 | Journal article
Source: Self-asserted source
Hilde Stevens

Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey

Frontiers in Medicine
2020-02-13 | Journal article
DOI: 10.3389/fmed.2020.00036
Part of ISSN: 2296-858X
Source: Self-asserted source
Hilde Stevens

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

BMC medical informatics and decision making
2019-10 | Journal article
DOI: 10.1186/s12911-019-0875-z
PMID: 31585538
PMC: PMC6778383
Contributors: Janssens R; Huys I; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Ciaglia A; Simoens S; Stevens H et al.
Source: Self-asserted source
Hilde Stevens via Europe PubMed Central

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.

The patient
2019-10 | Journal article
DOI: 10.1007/s40271-019-00367-w
PMID: 31222436
PMC: PMC6697755
Contributors: Janssens R; Russo S; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Bywall KS; Comanescu A; Hueber A et al.
Source: Self-asserted source
Hilde Stevens via Europe PubMed Central

From Opioid Pain Management to Opioid Crisis in the USA: How Can Public-Private Partnerships Help?

Frontiers in medicine
2019-05 | Journal article
DOI: 10.3389/fmed.2019.00106
PMID: 31157226
PMC: PMC6528705
Contributors: Bolliger L; Stevens H
Source: Self-asserted source
Hilde Stevens via Europe PubMed Central

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.

Frontiers in medicine
2018-10 | Journal article
DOI: 10.3389/fmed.2018.00285
PMID: 30364285
PMC: PMC6193089
Contributors: Janssens R; van Overbeeke E; Verswijvel L; Meeusen L; Coenegrachts C; Pauwels K; Dooms M; Stevens H; Simoens S; Huys I
Source: Self-asserted source
Hilde Stevens via Europe PubMed Central

Innovative Approaches to Increase Access to Medicines in Developing Countries.

Frontiers in medicine
2017-12 | Journal article
DOI: 10.3389/fmed.2017.00218
PMID: 29270407
PMC: PMC5725781
Contributors: Stevens H; Huys I
Source: Self-asserted source
Hilde Stevens via Europe PubMed Central

Intellectual property policies in early-phase research in public-private partnerships.

Nature biotechnology
2016-05 | Journal article
DOI: 10.1038/nbt.3562
PMID: 27153280
Contributors: Stevens H; Van Overwalle G; Van Looy B; Huys I
Source: Self-asserted source
Hilde Stevens via Europe PubMed Central

Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs).

Biotechnology law report
2015-08 | Journal article
DOI: 10.1089/blr.2015.29008.hs
PMID: 26396462
PMC: PMC4574745
Contributors: Stevens H; Van Overwalle G; Van Looy B; Huys I
Source: Self-asserted source
Hilde Stevens via Europe PubMed Central

Perspectives and Opportunities for Precompetitive Public–Private Partnerships in the Biomedical Sector

Biotechnology Law Report
2013-06 | Journal article
DOI: 10.1089/blr.2013.9929
Part of ISSN: 0730-031X
Part of ISSN: 1557-8704
Source: Self-asserted source
Hilde Stevens
How many people are using ORCID?